
Palobiofarma
Developer of adenosine receptor modulators designed to advance treatments for orphan and neurological diseases. The company offers virtual drug design, medicinal chemistry, in-vitro pharmacology exper...
Valuation
$79.3M
Latest known
Share Price
N/A
Total Raised
$21.1M
Last Round
N/A